- AutorIn
- David S. Baldwin University of Southampton, Faculty of Medicine, UK#University of Cape Town, Department of Psychiatry and Mental Health, South Africa
- Ian M. AndersonUniversity of Manchester, Neuroscience and Psychiatry Unit, UK
- David J. NuttImperial College London, Division of Experimental Medicine, UK
- Christer Allgulander
- Borwin Bandelow
- Johan A. den Boer
- David M. Christmas
- Simon Davies
- Naomi Fineberg
- Nicky Lidbetter
- Andrea Malizia
- Paul McCrone
- Daniel Nabarro
- Catherine O’Neill
- Jan Scott
- Nic van der Wee
- Hans-Ulrich Wittchen
- Titel
- Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder
- Untertitel
- A revision of the 2005 guidelines from the British Association for Psychopharmacology
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-353843
- Quellenangabe
- Journal of Psychopharmacology Erscheinungsort: London
Verlag: Sage
Erscheinungsjahr: 2014
Jahrgang: 28
Heft: 5
Seiten: 403-439
E-ISSN: 1461-7285 - Erstveröffentlichung
- 2014
- Abstract (EN)
- This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees.
- Andere Ausgabe
- Link zum Artikel, der zuerst in der Zeitschrift 'Journal of Psychopharmacology' erschienen ist.
DOI: 10.1177/0269881114525674 - Freie Schlagwörter (DE)
- Antikonvulsiva, Antidepressiva, Antipsychotika, Angststörungen, Anxiolytika, Benzodiazepine, kognitive Verhaltenstherapie, evidenzbasiert Leitlinien, generalisierte Angststörung, Zwangsstörung, Panikstörung, posttraumatische Belastungsstörung, Pregabalin, Trennungsangst-Störung, Serotonin-Noradrenalin-Wiederaufnahmehemmer, soziale Angststörung, spezifische Phobie, selektiver Serotonin-Wiederaufnahmehemmer, Behandlung
- Freie Schlagwörter (EN)
- Anticonvulsants, antidepressants, antipsychotics, anxiety disorders, anxiolytics, benzodiazepines, cognitive behaviour therapy, evidence-based guidelines, generalised anxiety disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, pregabalin, separation anxiety disorder, serotonin-noradrenaline reuptake inhibitor, social anxiety disorder, specific phobia, selective serotonin reuptake inhibitor, treatment
- Klassifikation (DDC)
- 610
- Verlag
- Sage, London
- Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:14-qucosa2-353843
- Veröffentlichungsdatum Qucosa
- 17.09.2019
- Dokumenttyp
- Artikel
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis